-- AHA Recognizes Use of IVTM Technology
-- The American Heart Association (AHA) and the International Liaison
Committee on Resuscitation (ILCOR) published an updated consensus
statement reiterating that therapeutic hypothermia should be part of
the standardized treatment strategy for comatose survivors of
cardiac arrest and, for the first time, cited intravascular
temperature management as a standard method for inducing
hypothermia. The statement appeared in the peer-reviewed journal
Circulation on October 28.
-- Regulatory Progress
-- Received clearance from the U.S. Food and Drug Administration to
market the Solex(TM) heat exchange catheter, which offers clinicians
maximum heat exchange power from a standard neck insertion, while
providing triple lumen central venous access.
-- Sales and Marketing Achievements
-- Increased the cumulative number of systems installed worldwide, with
more than 725 Alsius IVTM systems currently installed in
approximately 365 hospitals.
-- U.S. adoption of the newest IVTM system in Alsius' product line, the
Thermogard XP(TM), represented over 75 percent of systems sold
worldwide in the third quarter of 2008.
-- Revenue from European sales more than doubled during the third
quarter, compared to the same period last year.
-- Increased the percentage of revenues from sales of disposables.
-- Expanded customer financing options by providing short and long term
|SOURCE Alsius Corporation|
Copyright©2008 PR Newswire.
All rights reserved